ZYME 8-K: Buyback
Filed with the SEC on · accession 0001937653-26-000070
ZYME filed a 8-K (current report) with the SEC on Nov 16, 2026. A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
Summary of the filing
Zymeworks' Board of Directors authorized a second 2026 share repurchase program allowing the company to buy back up to $200.0 million of its outstanding common stock through 2028, following completion of its initial $125.0 million 2026 repurchase program.
Key details
✦ Ask GOAX AI about this filing — what it means for ZYME, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for ZYME?
Click hereFrequently asked questions
What did ZYME file with the SEC on Nov 16, 2026?
ZYME filed a 8-K (Buyback). Zymeworks' Board of Directors authorized a second 2026 share repurchase program allowing the company to buy back up to $200.0 million of its outstanding common stock through 2028, following completion of its initial $125.0 million 2026 repurchase program.
What does a buyback mean for ZYME stock?
Usually: fewer shares means each remaining share owns more of the company. It matters whether the company actually buys and at what price.
How do I read a 8-K?
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
Other ZYME SEC filings
Get alerts when ZYME files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days